The potential of hyperlipidemia to engage in the pathology of atherosclerotic diseases such as coronary heart disease, which dominates the scenario of diseases causing morbidity and mortality in the world. Hyperlipidemia is defined as elevated serum levels of cholesterol, triglycerides, or both. It is characterized by abnormally elevated lipid concentrations in blood caused by impaired lipid and lipoprotein metabolism and has the potential to cause a variety of complications such as cardiovascular disease, diabetes, obesity, hypertension, atherosclerosis, and so on. Hyperlipidemia is classified as Medoroga in Ayurveda. The results obtained for the lipid profile parameter demonstrated a significant change. The difference in total serum cholesterol is 36 mg/dl, serum triglycerides is 32 mg/dl, serum LDL is 40 mg/dl, serum VLDL is 15 mg/dl and serum HDL is -3 mg/dl.
Agnivesha. Charaka Samhita, redacted by Drudabala, with Ayurveda Deepika commentary by chakrapani Varanasi, Chaukamba Sanskrit Sansthana; reprint: 2004. Suthrasthana 28/45.
Astanga Samgraha with the commentary of Indu, Published by Central Council for research in Ayurveda and Siddha (CCRAS) New Delhi - 1991.
Astanga Hridaya with the commentaries, Sarvangasundara of Arundatta and Ayurveda Rasayana of Hemadri, edited by Pandit Hari Sadasiva Sastri Paradakara Bhisagacarya; Chaukhamba Orientalia, Varanasi, Ninth Edition, 2002.
Ayurveda Vidwan Prof. Murthy Srikanta KR, Sharangadhara Samhita, Third Edition-1997, with English Commentary, Bangalore, Chaukhambha Orientalia.
Bhaishajya Ratnavali, Govinda Das with Vidyotini Hindi commentary by Ambikadatta Shastri, editor Rajeshwar Datta Shastri, Chaukhambha Sanskrit Sansthana, 1987.
Bhavamishra. Bhava Prakasha with English Translation by Prof. K.R.Srikanta Murthy, 3rd edition, Varanasi, Choukhamba Krishna Das Academy, 2005.
Bhela Samhita, Sutrasthana, with English Translation by Krishnamurthy K.H., Varanasi; Chaukhambha Vishwabharati. Reprint 2006.
Chait A, Brunzell JD (June 1990). "Acquired hyperlipidemia (secondary dyslipoproteinemias)". Endocrinol. Metab. Clin. North Am. 19 (2): 259–278.
Chakrapanidatta. Chakradatta with vaidhya prabha Hindi commentary by Dr Indradev Tripathi, edited by Prof Ramanath Dwivedi, 1st edition Varanasi, Chaukhamba Sanskrit Sansthan, 1992.
Davidson’s Principal’s and practice of medicine, 19th edition page 308.
E.C.Warner: Savill’s System of Clinical Medicine, 14th edition, CBS Publications, 1998.
Frederickson DS, Lee RS. A system for phenotyping hyperlipidemia. Circulation 1965;31:321-7.
Harsh Mohan, Text Book of Pathology,15th chapter,6th edition, Jaypee Brothers Medical Publishers(P)Ltd. New Delhi, 2010.
Harita Samhita: Hariharprasada Tripathi Chaukhambha Sanskrit Sansthana, 2005.
Harrisons’s principles of internal medicineVol-2.; McGraw Hill book company 11th edition 1987.
Madhavakara. Madhava Nidanam with Madhu Kosha Sanskrit commentary by Shri. Vijayarakshita and Shrikanta Datta, with the Vidyotini Hindi commentary, edited by Yadunandana Upadhaya, Varanasi, Chaukhambha Sanskrit Sansthan, Part II, reprint 2003.
Sahastra Yogam, Hindi translation by Dr Ramnivas Sharma and Dr Surendra Sharma, 3rd edition, Varanasi: Chaukambha Vidhya Bhavan, 2002.
Sharangadhara Samhita with Adhamalla’s Deepika and Kashiram’s Gudartha Deepika commentary, Varanasi, Krishnadas Academy, reprint 2000.
Sushruta Samhita, the Nibandha Sangraha commentary by Dalhanacharya and the Nyayachandrika Panjika of Sri. Gayadasacharya on Nidana Sthana, edited by Vaidya Jadavji Trikamji Acharya and Narayanarama Acharya, Kavyatirtha, Chaukambha Surabharati, Varanasi; reprint 2003.
The Ayurvedic Formulary of India. Part I, Ministry of Health & Family Welfare, New Delhi: Government of India, 2nd edition, 2003.
Vangasena.Vangasena Samhita – with Hindi commentary from Dr. Rajiv Kumara Roy, edited by Dr. Rajiv Kumara Roy, 1st edition, Varanasi: Prachya Prakashan; 2000.
Yogaratnakar. With Vaidhya Prabha Hindi commentary, by Dr. Indradev Tripathi and Dr. Dayashankar Tripathi, Varanasi, Krishna Das Academy, 1st edition 1998.
This work is licensed under a Creative Commons Attribution 4.0 International License.